KabaFusion to accelerate growth with investment from Nautic Partners 

LEXINGTON, Mass. – KabaFusion has announced that Novo Holdings has exited its investment in the company and Nautic Partners has completed its growth investment in the company. 

KabaFusion says its clinician-led management team remains a significant investor and will continue to lead the company. 

“We are thrilled to partner with Nautic, whose deep health care expertise and collaborative approach will help accelerate our growth and expand access to high-quality infusion care,” said Dr. Sohail Masood, CEO and founder KabaFusion. “Nautic is a natural partner for us, sharing our commitment to delivering exceptional clinical outcomes through a patient-first model, and together we look forward to enhancing the experience for the patients and providers we serve.” 

Today, KabaFusion is licensed to serve patients in 45 states through its expansive network of 33 infusion pharmacies and 21 ambulatory infusion suites. 

This new growth partnership with Nautic will enable KabaFusion to accelerate and further expand its mission to serve patients, health care practitioners and payers nationwide with the highest quality home infusion services and unmatched clinical excellence, the company says. 

“We have long admired Dr. Masood and the KabaFusion team, who have earned their position as a distinguished leader in home infusion through differentiated clinical expertise and an unwavering patient-first culture,” said Joe Anderson, managing director at Nautic Partners. “We are excited to partner with Dr. Masood and his team to support continued innovation and expand access to the highest quality of care.” 

Nautic Partners is a middle-market private equity firm based in Providence, R.I., that focuses on investments in three sectors: health care, industrial and services. It has completed more than 160 platform transactions over its 38-year history.   

Other recent KabaFusion news: 

• KabaFusion has closed on the acquisition of six locations from Coram that will serve as pharmacies and ambulatory infusion suites. 

• Memorial Hermann Health System has established a services agreement with KabaFusion to provide home infusion therapy for patients with chronic conditions and for those who need intravenous immunoglobulin (IVIG) treatment.